On Jun 27, 2018 SunTrust Robinson Humphrey Covered Eloxx Pharmaceuticals (ELOX) with $26 Target.

June 27, 2018 - By Anthony Rauscher

What Price Target Has SunTrust Robinson Humphrey Given Eloxx Pharmaceuticals (ELOX)

With “Buy” rating that means 32.18 % upside potential on Eloxx Pharmaceuticals (ELOX), SunTrust Robinson Humphrey has begun coverage of ELOX’s shares on Tuesday morning.

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Ratings Coverage

Total analysts of 3 have positions in Eloxx Pharmaceuticals (ELOX) as follows: 3 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. Since May 1, 2018 according to StockzIntelligence Inc Eloxx Pharmaceuticals has 3 analyst reports. On Friday, June 8 the stock of Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) has “Buy” rating given by Piper Jaffray.

The stock increased 4.35% or $0.82 during the last trading session, reaching $19.67.Eloxx Pharmaceuticals, Inc. is uptrending after having risen 234.17% since June 27, 2017. ELOX has 290,153 volume or 61.10% up from normal. ELOX outperformed by 221.60% the S&P 500.

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases.The company has $657.51 million market cap. The Company’s lead program is ELX-02, which is in Phase I clinical trial, which focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations.Last it reported negative earnings.

For more Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) news brought out briefly go to: Streetinsider.com, Streetinsider.com, Nasdaq.com, Prnewswire.com or Benzinga.com. The titles are as follows: “After-Hours Stock Movers 06/25: (XERS) (BLDP) (EXEL) Higher; (GEVO) (SENS) (HRTX) Lower (more…)” brought out on June 25, 2018, “Pre-Open Movers 06/26: (LEE) (SPPI) (GE) Higher; (GEVO) (SENS) (AKAM) Lower (more…)” on June 26, 2018, “Eloxx Appoints Global Pharmaceutical Leader, Neil Belloff, Executive Vice President, General Counsel and Corporate …” with a publish date: June 18, 2018, “Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update” and the last “Benzinga’s Top Upgrades, Downgrades For June 26, 2018” with publication date: June 26, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.